Australia markets close in 3 hours 21 minutes

TC Biopharm (Holdings) Plc (TCBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.3500+0.0200 (+1.50%)
At close: 04:00PM EDT
1.4700 +0.12 (+8.89%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.22M
Enterprise value 3.39M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.51
Price/book (mrq)1.26
Enterprise value/revenue 1.83
Enterprise value/EBITDA -0.54

Trading information

Stock price history

Beta (5Y monthly) 0.33
52-week change 3-99.55%
S&P500 52-week change 321.61%
52-week high 3320.0000
52-week low 30.8500
50-day moving average 31.3823
200-day moving average 346.1241

Share statistics

Avg vol (3-month) 34.73M
Avg vol (10-day) 39.14M
Shares outstanding 53.2M
Implied shares outstanding 63.2M
Float 863.77M
% held by insiders 10.03%
% held by institutions 12.41%
Shares short (28 Mar 2024) 4204.48k
Short ratio (28 Mar 2024) 40.03
Short % of float (28 Mar 2024) 48.43%
Short % of shares outstanding (28 Mar 2024) 48.43%
Shares short (prior month 29 Feb 2024) 4196.99k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 315 Dec 2023

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-88.01%
Return on equity (ttm)-391.64%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -13.61M
Net income avi to common (ttm)-5.91M
Diluted EPS (ttm)-23.9300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.46M
Total cash per share (mrq)0.04
Total debt (mrq)1.8M
Total debt/equity (mrq)67.08%
Current ratio (mrq)1.20
Book value per share (mrq)2.61

Cash flow statement

Operating cash flow (ttm)-10.54M
Levered free cash flow (ttm)-12.23M